ID

20356

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 5 (Month 12) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Keywords

Versions (1)
  1. 2/21/17 2/21/17 -
Uploaded on

February 21, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

English

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 forms  
Concomitant Medication
Description

Concomitant Medication

Alias
UMLS CUI-1
C2347852
1. Since visit 2, were any of the non-study medications listed below taken?
Description

Concomitant medication

Data type

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
If yes, please indicate which of the following were taken:
Description

If yes, please indicate which

Data type

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1524063
ACE Inhibitors
Description

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
2. Since visit 2, were any ACE inhibitors taken?
Description

ACE Inhibitors currently taken

Data type

boolean

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
If yes, please indicate which, and total daily dose:
Description

If yes

Data type

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
UMLS CUI [2]
C2348070
Restricted Concomitant Medication
Description

Restricted Concomitant Medication

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0443288
3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
Description

Restricted medication taken

Data type

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
UMLS CUI [1,4]
C0443288
If yes, please indicate which category
Description

if yes

Data type

integer

Alias
UMLS CUI [1,1]
C0683312
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C0443288
Back to the top of the page

Similar models

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant medication
Item
1. Since visit 2, were any of the non-study medications listed below taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
Item
If yes, please indicate which of the following were taken:
integer
C2347852 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes, please indicate which
Code List
If yes, please indicate which of the following were taken:
CL Item
Parental anticoagulants (Short term use)  (1)
CL Item
Oral anticoagulants (Short term use) (2)
CL Item
Nitrates (oral or topical) (3)
CL Item
Estrogen replacement without progesterone (4)
CL Item
Estrogen replacement with progesterone (5)
CL Item
Digitalis (6)
CL Item
Statins (7)
CL Item
Fibrates (8)
CL Item
Dilitazem/Verapamil (9)
CL Item
Other calcium channel blockers (10)
CL Item
Alpha-blocker (11)
CL Item
Direct vasodilators (12)
CL Item
Peripheral sympatholytic (13)
CL Item
Central sympatholytic (14)
CL Item
Alpha-beta blocker (15)
CL Item
Beta-blocker (16)
CL Item
Loop-active diuretics (17)
CL Item
Diuretics of thiazide type (18)
CL Item
Potassium-sparing diuretics (19)
CL Item
Insulin (20)
CL Item
Oral hypoglycemic agents (21)
CL Item
Specific Cox II inhibitors (22)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
2. Since visit 2, were any ACE inhibitors taken?
boolean
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes
Item
If yes, please indicate which, and total daily dose:
text
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C2348070 (UMLS CUI [2])
Item Group
Restricted Concomitant Medication
C2347852 (UMLS CUI-1)
C0443288 (UMLS CUI-2)
Restricted medication taken
Item
3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
C0443288 (UMLS CUI [1,4])
Item
If yes, please indicate which category
integer
C0683312 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0443288 (UMLS CUI [1,3])
if yes
Code List
If yes, please indicate which category
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
6 (6)
CL Item
7 (7)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial